Find a Dermatologist | Dermatologist Directory | Dermatology Resources Online
Medicine News » Dermatology News » Dyax and Eclipse Therapeutics Announce Oncology Antibody License Agreement - MarketWatch (press release)
 

Dyax and Eclipse Therapeutics Announce Oncology Antibody License Agreement - MarketWatch (press release)

Posted on April 19th, 2012, 9:56 am


Mass High Tech

Dyax and Eclipse Therapeutics Announce Oncology Antibody License Agreement
MarketWatch (press release)
(NASDAQ:DYAX) and Eclipse Therapeutics, Inc., a privately held oncology company, announced today that Dyax has granted Eclipse an exclusive worldwide license for the development and commercialization of preclinical fully-human antibodies discovered ...

Recommend this news article 0